American Pharma giant Johnson and Johnson seeks permission for phase 3 trial of its single-shot Covid-19 vaccine on Monday.
The company has sought grant of import license in India, reported PTI.
They said the company has sought an early meeting of the subject expert committee on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application.
J&J is the only manufacturer with single-shot vaccine against Covid-19, though the vaccine has been banned in certain countries due to blood clot rumours.
Explore the profound effects of excessive screen time on your child’s behavior and development. Discover…
Discover how simple daily changes in your diet and lifestyle can significantly improve your heart…
This article explores the common misconception that brain tumours primarily affect older adults, revealing the…
The first-ever ovarian cancer vaccine is poised to change the landscape of women's health by…
As dengue and chikungunya cases rise in Delhi during the monsoon season, understanding prevention strategies…
Skincare is a significant concern for women (and increasingly, men), with the quest for perfect,…